Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Can... 由 Sofie H. Tolmeijer (15313251)

主題:

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Can... 由 Sofie H. Tolmeijer (15313251)

主題:

Supplementary Data 3 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation 由 Priyanka Gopal (15050862)

主題:

Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients 由 Javier Pascual (15018176)

主題:

Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4⁺ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance 由 Ankita Mitra (17141783)

主題:

Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation 由 Priyanka Gopal (15050862)

主題:

Supplementary Data 4 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation 由 Priyanka Gopal (15050862)

主題:

Supplementary Data 2 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation 由 Priyanka Gopal (15050862)

主題:

Supplementary Data 1 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation 由 Priyanka Gopal (15050862)

主題:

CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4⁺ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance 由 Ankita Mitra (17141783)

主題:

Supplementary Data 5 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation 由 Priyanka Gopal (15050862)

主題:

Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients 由 Javier Pascual (15018176)

主題:

Supplementary Table S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients 由 Javier Pascual (15018176)

主題:

Supplementary Figure S4 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients 由 Javier Pascual (15018176)

主題:

Supplementary Figure S1 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients 由 Javier Pascual (15018176)

主題:

Supplementary Figure S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients 由 Javier Pascual (15018176)

主題:

Supplementary Figure S5 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients 由 Javier Pascual (15018176)

主題:

Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4⁺ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance 由 Ankita Mitra (17141783)

主題:

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cance... 由 Emil Christensen (15054394)

主題:

Supplementary Tables S1-5 from METTL3-Mediated m⁶A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL 由 Yiming Wu (15306005)

主題: